Results 101 to 110 of about 927,770 (119)

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours. [PDF]

open access: yesBr J Cancer, 2019
Serrano C   +18 more
europepmc   +1 more source

Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma. [PDF]

open access: yesBr J Cancer, 2014
Peiró G   +11 more
europepmc   +1 more source

El fenotipo de las mucinas en el esófago de Barrett: Mucin phenotypes in Barrett's esophagus. [PDF]

open access: yesRev Esp Patol, 2010
Torrado J   +7 more
europepmc   +1 more source

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. [PDF]

open access: yesSci Rep, 2018
Horne HN   +51 more
europepmc   +1 more source

Targeting the epigenetics of the DNA damage response in breast cancer. [PDF]

open access: yesCell Death Dis, 2016
Montenegro MF   +5 more
europepmc   +1 more source

In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning. [PDF]

open access: yesEMBO J, 2014
Formentini L   +7 more
europepmc   +1 more source

Predicting response and survival in chemotherapy-treated triple-negative breast cancer. [PDF]

open access: yesBr J Cancer, 2014
Prat A   +37 more
europepmc   +1 more source

Suppression of antifolate resistance by targeting the myosin Va trafficking pathway in melanoma. [PDF]

open access: yesNeoplasia, 2013
Fernández-Pérez MP   +7 more
europepmc   +1 more source

5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. [PDF]

open access: yesGastroenterology, 2011
Jover R   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy